Heart Failure 2012
Overview
Overview
Journal
Cardiol Res Pract
Publisher
Wiley
Specialty
Cardiology & Vascular Diseases
Date
2013 Jan 16
PMID
23320244
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Giamouzis G, Triposkiadis F, Georgiopoulou V, Farmakis D, Westermann D, Skoularigis J Cardiol Res Pract. 2014; 2013:342316.
PMID: 24490099 PMC: 3893788. DOI: 10.1155/2013/342316.
References
1.
Kazemi-Bajestani S, Patel V, Wang W, Oudit G
. Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges. Cardiol Res Pract. 2012; 2012:823193.
PMC: 3359660.
DOI: 10.1155/2012/823193.
View
2.
Giamouzis G, Triposkiadis F, Butler J, Westermann D, Giannakoulas G
. Heart failure. Cardiol Res Pract. 2011; 2011:159608.
PMC: 3124136.
DOI: 10.4061/2011/159608.
View
3.
Kalogeropoulos A, Georgiopoulou V, Giamouzis G, Smith A, Agha S, Waheed S
. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol. 2009; 53(4):334-42.
DOI: 10.1016/j.jacc.2008.10.023.
View
4.
Lindner D, Hilbrandt M, Marggraf K, Becher P, Hilfiker-Kleiner D, Klingel K
. Protective Function of STAT3 in CVB3-Induced Myocarditis. Cardiol Res Pract. 2012; 2012:437623.
PMC: 3366200.
DOI: 10.1155/2012/437623.
View
5.
Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith A, Dunbar S
. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2010; 17(1):54-75.
DOI: 10.1016/j.cardfail.2010.08.010.
View